|
Regulations on Administrative Protection for Pharmaceuticals
Approved by the State Council on December 12, 1992 and promulgated by the
State Pharmaceutical Administration on December 19, 1992.
CHAPTER I GENERAL PROVISIONS
Article 1 These Regulations are
enacted with a view to expanding economic and technological cooperation and
exchange with foreign countries, providing Administrative Protection to the
lawful rights and interests of the owners of the exclusive right of foreign
pharmaceuticals.
Article 2 The
"pharmaceuticals", as mentioned in these Regulations, refers to medicines for
human beings.
Article 3 Enterprises and other
organizations and individuals from the country or the region, which has
concluded bilateral treaty or agreement with the People's Republic of China on
administrative protection for pharmaceuticals, may apply for Administrative
Protection for Pharmaceuticals in accordance with these Regulations.
Article 4 The competent authorities for
the production and distribution of pharmaceuticals under the State Council
receives and examines applications for Administrative Protection for
Pharmaceuticals, grants Administrative Protection to the pharmaceuticals which
conform with the provisions of these Regulations, and issues the Certificate for
Administrative Protection for Pharmaceuticals to the applicants.
CHAPTER II APPLICATION FOR ADMINISTRATIVE
PROTECTION
Article 5 A pharmaceutical which can be applied for Administrative Protection
shall meet the following requirements:
(1) Was not subject to protection by exclusive rights in
accordance with the provisions of the
China's Patent Law prior to January 1, 1993;
(2) Is subject to an exclusive right to prohibit others from
making, using or selling it in the country to which the applicant belongs, which
was granted after January 1, 1986 and before January 1, 1993;
(3) Has not been marketed in China prior to the date of filing
the application for administrative protection.
Article 6 The right of applying for Administrative Protection for
Pharmaceuticals belongs to the owner of the exclusive right of the
pharmaceutical.
Article 7 Where an owner of the exclusive right of a foreign pharmaceutical
applies for Administrative Protection, he or it shall appoint an agency
designated by the competent authorities for the production and distribution of
pharmaceuticals under the State Council to act as his or its agent.
Article 8 An applicant shall provide the following documents both in Chinese
and the original:
(1) An Application for Administrative Protection for
Pharmaceuticals;
(2) A copy of the certificate issued by the competent authorities
of country to which the applicant belongs granting such exclusive right;
(3) A copy of the document issued by the competent authorities of
the country to which the applicant belongs for the approval for manufacture or
marketing of such pharmaceutical;
(4) A copy of a contract for the manufacture and / or marketing
formally entered into between the applicant and a Chinese enterprise as legal
person (including wholly foreign capital enterprises , Chinese - foreign joint
venture enterprises, or Chinese - foreign cooperative enterprises), which has
obtained approval for manufacture or marketing of pharmaceuticals in accordance
with the relevant Chinese laws and regulations , with respect to the manufacture
and / or marketing of the pharmaceutical in China.
Article 9 Prior to or after applying for
the Administrative Protection, the owner of the exclusive right of a foreign
pharmaceutical shall apply to the administrative department of health under the
State Council for going through the procedures of approval for manufacturing or
marketing of the pharmaceutical in China, in accordance with the provisions of
the Pharmaceutical Administration Law of the People's Republic of China.
CHAPTER III EXAMINATION AND APPROVAL OF
APPLICATION FOR ADMINISTRATIVE PROTECTION
Article 10 Within 15 days from the date of receipt of the application
documents for Administrative Protection, the competent authorities for the
production and distribution of pharmaceuticals of the State Council, upon
preliminary examination, shall make the following decisions according to
different conditions:
(1) Where the application documents are
in conformity with the pro-visions of Article 8 of these Regulations, issue the
notice of acceptance and announce it;
(2) Where the application documents are
not in conformity with the provisions of Article 8 of these Regulations, request
the applicant to complement within a definite time; if the time limit for making
complement is not met, the application shall be deemed to have not been
filed.
Article 11 The competent authorities for the production and
distribution of pharmaceuticals under the State Council shall finish the
examination within six months from the date of receipt of the application
documents, or from the date of receipt of the complementary documents stipulated
in Article 10(2) of these Regulations. If, under special circumstances, the
examination cannot be finished within six months, the competent authorities for
the production and distribution of pharmaceuticals under the State Council shall
promptly notify the applicant, inform the reason and properly prolong the
examination time.
After examination, where the application is in conformity with the provisions
of these Regulations, Administrative Protection shall be granted; Where the
application is not in conformity with the provisions of these Regulations, no
Administrative Protection shall be granted and the reason shall be informed.
Article 12 Where a pharmaceutical
is granted with Administrative Protection, the competent authorities for the
production and distribution of pharmaceuticals under the State Council shall
issue the Certificate for Administrative Protection for Pharmaceuticals and make
an announcement.
CHAPTER IV DURATION, CESSATION, REVOCATION
AND EFFECT OF ADMINISTRATIVE PROTECTION
Article 13 The term of Administrative Protection begins from the date
on which the Certificate for Administrative Protection for Pharmaceuticals is
issued and remains in force for seven years and six months.
Article 14 The owner of the exclusive right of a foreign pharmaceutical
shall pay an annual fee beginning with the year in which the Certificate for
Administrative Protection for Pharmaceuticals is issued.
Article 15 In any of the following cases, Administrative Protection
shall cease before the expiration of its duration:
(1) Where the exclusive right of a
pharmaceutical had been invalid or had lost efficacy in the country to which the
applicant belongs;
(2) Where the owner of the exclusive
right of a pharmaceutical does not pay an annual fee as prescribed;
(3) Where the owner of the exclusive
right of a pharmaceutical abandons the
administrative protection by a written declaration;
(4) Where the owner of the exclusive
right of a pharmaceutical does not apply to the administrative department of
health under the State Council for going through the procedures of approval for
manufacture or marketing of this pharmaceutical in China within a year from the
date on which the Certificate for Administrative Protection for Pharmaceuticals
is issued.
Article 16 Where, after the Certificate for Administrative Protection
for Pharmaceuticals has been issued, any organization or individual thinks that
the grant of Administrative Protection to the subject pharmaceutical is not in
conformity with the provisions of these Regulations, it or he may request the
competent authorities for the production and distribution of pharmaceuticals
under the State Council to revoke the Administrative Protection of the subject
pharmaceutical. Where the owner of the exclusive right of the
pharmaceutical is not satisfied with the revocation decision made by the
competent authorities for the production and distribution of pharmaceuticals
under the State Council, it or he may institute legal proceedings in the
people's court.
Article 17 The cessation or revocation of Administrative Protection for
Pharmaceuticals shall be announced by the competent authorities for the
production and distribution of pharmaceuticals under the State Council.
Article 18 For the pharmaceuticals which have obtained Administrative
Protection, without the authorization of the owners of the exclusive right of
the pharmaceuticals, the administrative department of health under the State
Council and the administrative departments of health of provinces, autonomous
regions or municipalities directly under the Central Government shall not ratify
others to manufacture or sell them.
Article 19 Where there is any manufacture or marketing of a
pharmaceutical without authorization of the owner of the exclusive right of the
pharmaceutical who has obtained Administrative Protection, the owner of the
exclusive right of the pharmaceutical may request the competent authorities for
the production and distribution of pharmaceuticals under the State Council to
stop the infringing act; if the owner of the exclusive right of the
pharmaceutical requests for economic compensation, he or it may institute legal
proceedings in the people's court.
CHAPTER V SUPPLEMENTARY PROVISIONS
Article 20 The competent
authorities for the production and distribution of pharmaceuticals under the
State Council shall take measures to keep secret all the materials provided by
applicants which requires to be kept secret.
Article 21 Any application for Administrative Protection for
Pharmaceuticals filed with, and any other relevant proceedings before, the
competent authorities for the production and distribution of pharmaceuticals
under the State Council shall be subject to the payment of a fee as
prescribed.
Article 22 The rules for the implementation of these Regulations shall
be formulated by the competent authorities for the production and distribution
of pharmaceuticals under the State Council.
Article 23 The competent authorities for the production and
distribution of pharmaceuticals under the State Council shall be responsible for
the interpretation of these Regulations.
Article 24 These Regulations shall enter into force on January 1,
1993. |